Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

J App Pharm Sci. 2023; 13(12): 41-51


Systematized review of the innovative Russian IT-solutions for the optimization of drug information in the circulation of medicines

Alexander Sergeevich Belosludtsev, Tatiana Mikhailovna Litvinova.




Abstract
Cited by 0 Articles

An increase in the number of new drug products (DPs) leads to the growth in the associated information. To improve the efficiency of medical and pharmaceutical care, IT-products are created. In this review, we attempt to systematize innovative domestic IT-solutions (dITSs) for the optimization of remote data management of medicines. We have conducted a systematized search over the past 5 years in accordance with the PRISMA framework. eLibrary, CyberLeninka, and Google were utilized as search engines. 18 out of 312 results met the preset criteria. 23 dITSs were extracted. 18 used big data as the main technology, 2 blockchains, 2 artificial intelligence, and 1 continuous acquisition and lifecycle support/product lifecycle management. The innovations point towards the optimization of drug information in medical organizations (16/23) and pharmacies (6/23). In practice, the dITSs are mainly used as databases (10/23), decision support systems (9/23), and automated analytics (6/23). Specific products are infrequently and not comprehensively assessed in scientific papers. It is more efficient to search them on particular sites dedicated to IT-projects. Today’s reasons for the development of the innovative dITSs to optimize information management within the lifecycle of medicines are a necessity to trace each DP and automate the analysis of related information.

Key words: drug information, information technologies, telepharmacy, information management, optimization






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.